Sign In
Buy OCGN
$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
New York, New York--(Newsfile Corp. - June 23, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging tha
8 Hot Biotech Penny Stocks For Your July 2021 Watch List
11:27am, Wednesday, 23'rd Jun 2021
Current & Former Penny Stocks To Watch Before July The post 8 Hot Biotech Penny Stocks For Your July 2021 Watch List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
New York, New York--(Newsfile Corp. - June 22, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ocugen, Inc. - OCGN
06:02pm, Tuesday, 22'nd Jun 2021
NEW YORK, June 22, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN). Such investors are advised to cont
Lawsuit Filed: Ocugen Sued for Violations of Federal Securities Laws; Investors Should Contact Block & Leviton
04:00pm, Tuesday, 22'nd Jun 2021
Boston, Massachusetts--(Newsfile Corp. - June 22, 2021) - Block & Leviton announces that a lawsuit for violations of federal securities laws has been filed against Ocugen, Inc. (NASDAQ: OCGN) and cert
What's Next For Ocugen Stock As It Bounces Off Support?
03:05pm, Tuesday, 22'nd Jun 2021
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday, likely making a correction after shares saw a nice gain Monday. Ocugen was down 5.14% at $7.02 at last check.
New York, New York--(Newsfile Corp. - June 22, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging that
NEW YORK, June 22, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ocugen, Inc. ("Ocugen" or "th
Los Angeles, California--(Newsfile Corp. - June 22, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocu
OCGN Stock Price Increases Over 2% Pre-Market: Why It Happened
08:20am, Tuesday, 22'nd Jun 2021
The stock price of Ocugen Inc (NASDAQ: OCGN) increased by over 2% pre-market. This is why it happened.
SHAREHOLDER ALERT: Robbins LLP Announces That Ocugen, Inc. (OCGN) Is Being Sued for Misleading Shareholders
07:48pm, Monday, 21'st Jun 2021
SAN DIEGO & MALVERN, Pa.--(BUSINESS WIRE)---- $OCGN #LawFirm--Shareholder rights law firm Robbins LLP announces that a class action has been filed on behalf of all purchasers of Ocugen, Inc. (NASDAQ:
New York, New York--(Newsfile Corp. - June 21, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
LOS ANGELES--(BUSINESS WIRE)---- $OCGN #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on be
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
12:15pm, Monday, 21'st Jun 2021
LOS ANGELES--(BUSINESS WIRE)---- $OCGN #investors--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
Ocugen, Inc. Announces Ken Inchausti as Head, Investor Relations & Communications
09:12am, Monday, 21'st Jun 2021
MALVERN, Pa., June 21, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseas
